Results 301 to 310 of about 371,827 (350)
Some of the next articles are maybe not open access.
Current Oncology Reports, 2002
Peripheral (post-thymic) T-cell lymphoma consists of a wide spectrum of disorders with marked differences in biology and behavior. Proper classification is pivotal for evaluating treatment results, and most studies performed a decade ago lump together different disease entities and cannot be interpreted.
Wing Y, Au, Raymond, Liang
openaire +2 more sources
Peripheral (post-thymic) T-cell lymphoma consists of a wide spectrum of disorders with marked differences in biology and behavior. Proper classification is pivotal for evaluating treatment results, and most studies performed a decade ago lump together different disease entities and cannot be interpreted.
Wing Y, Au, Raymond, Liang
openaire +2 more sources
Hématologie, 2014
Les lymphomes T peripheriques (LTP) sont des maladies tumorales lymphoides qui derivent des cellules T ou natural killer (NK). C’est un groupe heterogene representant 10-15 % des lymphomes non hodgkiniens (LNH), soit environ 1 300 nouveaux cas par an en France. Malgre leur faible frequence, ils sont d’une grande diversite.
Olivier Tournilhac +2 more
openaire +1 more source
Les lymphomes T peripheriques (LTP) sont des maladies tumorales lymphoides qui derivent des cellules T ou natural killer (NK). C’est un groupe heterogene representant 10-15 % des lymphomes non hodgkiniens (LNH), soit environ 1 300 nouveaux cas par an en France. Malgre leur faible frequence, ils sont d’une grande diversite.
Olivier Tournilhac +2 more
openaire +1 more source
Hematology/Oncology Clinics of North America, 2009
Peripheral T-cell lymphomas (PTCLs) are malignancies of immunologically mature T-cells that arise in peripheral lymphoid tissues such as lymph nodes, spleen, gastrointestinal tract, and skin. These lymphomas are uncommon as compared with the incidence of B-cell lymphomas, and they comprise only 5% to 10% of non-Hodgkin lymphomas in North America and ...
openaire +2 more sources
Peripheral T-cell lymphomas (PTCLs) are malignancies of immunologically mature T-cells that arise in peripheral lymphoid tissues such as lymph nodes, spleen, gastrointestinal tract, and skin. These lymphomas are uncommon as compared with the incidence of B-cell lymphomas, and they comprise only 5% to 10% of non-Hodgkin lymphomas in North America and ...
openaire +2 more sources
Blood Reviews, 2007
Peripheral T-cell lymphomas (PTCLs) are a biologically diverse and uncommon group of diseases. Compared to their B-cell counterparts, PTCLs remain largely unexplored and the optimal treatment ill-defined due to disease rarity and biological heterogeneity. With the notable exception of ALK-pos anaplastic large cell lymphoma (ALCL), the prognosis of most
openaire +2 more sources
Peripheral T-cell lymphomas (PTCLs) are a biologically diverse and uncommon group of diseases. Compared to their B-cell counterparts, PTCLs remain largely unexplored and the optimal treatment ill-defined due to disease rarity and biological heterogeneity. With the notable exception of ALK-pos anaplastic large cell lymphoma (ALCL), the prognosis of most
openaire +2 more sources
Update: Peripheral T-Cell Lymphomas
Current Hematologic Malignancy Reports, 2011Peripheral T-cell lymphomas (PTCLs) are a group of biologically heterogeneous but typically aggressive diseases. Progress in understanding and developing optimal therapies for PTCLs has been hampered by disease rarity and only relatively recent recognition of the importance of the T-cell phenotype.
openaire +2 more sources
Pediatric Blood & Cancer, 2020
Pediatric‐type follicular (PTFL), marginal zone (MZL), and peripheral T‐cell lymphoma (PTCL) account each for
A. Attarbaschi +16 more
semanticscholar +1 more source
Pediatric‐type follicular (PTFL), marginal zone (MZL), and peripheral T‐cell lymphoma (PTCL) account each for
A. Attarbaschi +16 more
semanticscholar +1 more source
Journal of Clinical Oncology, 1987
Thirty-one Chinese patients with peripheral T cell lymphoma (PTCL) were reviewed. Using the modified Japanese Lymphoma Group classification, there were nine (29%) of the pleomorphic type, 16 (52%) immunoblastic lymphadenopathy (IBL)-like, two (7%) T-zone lymphoma, and one (3%) Lennert's lymphoepithelioid type. Three (9%) were not classifiable.
R, Liang +5 more
openaire +2 more sources
Thirty-one Chinese patients with peripheral T cell lymphoma (PTCL) were reviewed. Using the modified Japanese Lymphoma Group classification, there were nine (29%) of the pleomorphic type, 16 (52%) immunoblastic lymphadenopathy (IBL)-like, two (7%) T-zone lymphoma, and one (3%) Lennert's lymphoepithelioid type. Three (9%) were not classifiable.
R, Liang +5 more
openaire +2 more sources
Nouvelle revue francaise d'hematologie, 1985
We report three cases of malignant T cell lymphoma of peripheral T lymphocyte origin. This morphological entity was first described by Lennert and Waldron. The diagnosis based on morphological criteria only is difficult because of the many lymphoid malignancies.
N, Horschowski +6 more
openaire +1 more source
We report three cases of malignant T cell lymphoma of peripheral T lymphocyte origin. This morphological entity was first described by Lennert and Waldron. The diagnosis based on morphological criteria only is difficult because of the many lymphoid malignancies.
N, Horschowski +6 more
openaire +1 more source
Romidepsin for peripheral T-cell lymphoma
Expert Review of Hematology, 2013Peripheral T-cell lymphoma (PTCL) is comprised of a rare heterogeneous group of diseases with diverse clinical presentations; however outcomes associated with conventional chemotherapy are generally poor in the majority of patients. Newer approaches, which include dose-intensification and agents with novel mechanisms of action, are needed to improve ...
Amit, Khot +2 more
openaire +2 more sources